These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 26081836)

  • 1. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
    Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
    Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics.
    Jin H; Cheng X; Pei Y; Fu J; Lyu Z; Peng H; Yao Q; Jiang Y; Luo L; Zhuo H
    J Proteomics; 2016 Mar; 136():77-88. PubMed ID: 26721444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
    Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
    J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkers.
    Tomiyama E; Matsuzaki K; Fujita K; Shiromizu T; Narumi R; Jingushi K; Koh Y; Matsushita M; Nakano K; Hayashi Y; Wang C; Ishizuya Y; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Adachi J; Tomonaga T; Nonomura N
    Cancer Sci; 2021 May; 112(5):2033-2045. PubMed ID: 33721374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins.
    Guo J; Ren Y; Hou G; Wen B; Xian F; Chen Z; Cui P; Xie Y; Zi J; Lin L; Wu S; Li Z; Wu L; Lou X; Liu S
    J Proteome Res; 2016 Jul; 15(7):2164-77. PubMed ID: 27265680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.
    Chi LM; Lee CW; Chang KP; Hao SP; Lee HM; Liang Y; Hsueh C; Yu CJ; Lee IN; Chang YJ; Lee SY; Yeh YM; Chang YS; Chien KY; Yu JS
    Mol Cell Proteomics; 2009 Jul; 8(7):1453-74. PubMed ID: 19297561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of the cancer cell secretome and transcriptome reveals potential noninvasive diagnostic markers for bladder cancer.
    Chen YT; Tu WJ; Ye ZH; Wu CC; Ueng SH; Yu KJ; Chen CL; Peng PH; Yu JS; Chang YH
    Proteomics Clin Appl; 2024 Jul; 18(4):e202300033. PubMed ID: 38196148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity.
    Liu PF; Wang YH; Cao YW; Jiang HP; Yang XC; Wang XS; Niu HT
    Oncol Rep; 2014 Oct; 32(4):1489-96. PubMed ID: 25050759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Proteomic Analysis Identifies AHNAK (Neuroblast Differentiation-associated Protein AHNAK) as a Novel Candidate Biomarker for Bladder Urothelial Carcinoma Diagnosis by Liquid-based Cytology.
    Lee H; Kim K; Woo J; Park J; Kim H; Lee KE; Kim H; Kim Y; Moon KC; Kim JY; Park IA; Shim BB; Moon JH; Han D; Ryu HS
    Mol Cell Proteomics; 2018 Sep; 17(9):1788-1802. PubMed ID: 29950347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery.
    Xiao H; Langerman A; Zhang Y; Khalid O; Hu S; Cao CX; Lingen MW; Wong DTW
    Oral Oncol; 2015 Nov; 51(11):1011-1019. PubMed ID: 26321370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma.
    Elsner M; Rauser S; Maier S; Schöne C; Balluff B; Meding S; Jung G; Nipp M; Sarioglu H; Maccarrone G; Aichler M; Feuchtinger A; Langer R; Jütting U; Feith M; Küster B; Ueffing M; Zitzelsberger H; Höfler H; Walch A
    J Proteomics; 2012 Aug; 75(15):4693-704. PubMed ID: 22365974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis.
    Liu PF; Cao YW; Jiang HP; Wang YH; Yang XC; Wang XS; Niu HT
    Med Oncol; 2014 Sep; 31(9):21. PubMed ID: 25085780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profilin 1 is a potential biomarker for bladder cancer aggressiveness.
    Zoidakis J; Makridakis M; Zerefos PG; Bitsika V; Esteban S; Frantzi M; Stravodimos K; Anagnou NP; Roubelakis MG; Sanchez-Carbayo M; Vlahou A
    Mol Cell Proteomics; 2012 Apr; 11(4):M111.009449. PubMed ID: 22159600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis.
    Zhang Y; Ye Y; Shen D; Jiang K; Zhang H; Sun W; Zhang J; Xu F; Cui Z; Wang S
    Cancer Sci; 2010 Feb; 101(2):523-9. PubMed ID: 19930159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
    Zhu J; Nie S; Wu J; Lubman DM
    J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
    Chen YT; Huang HC; Hsieh YJ; Fu SH; Li L; Chen CL; Chu LJ; Yu JS
    J Food Drug Anal; 2019 Apr; 27(2):460-474. PubMed ID: 30987717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics.
    Chen CL; Lin TS; Tsai CH; Wu CC; Chung T; Chien KY; Wu M; Chang YS; Yu JS; Chen YT
    J Proteomics; 2013 Jun; 85():28-43. PubMed ID: 23631828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.